Table of Contents Chapter 1 Overview of Parathyroid Hormone Analog 1.1 Definition of Parathyroid Hormone Analog in This Report 1.2 Commercial Types of Parathyroid Hormone Analog 1.2.1 Abaloparatide 1.2.2 Teriparatide 1.2.3 Human parathyroid hormone Recombinant 1.3 Downstream Application of Parathyroid Hormone Analog 1.3.1 Osteoporosis 1.4 Development History of Parathyroid Hormone Analog 1.5 Market Status and Trend of Parathyroid Hormone Analog 2013-2023 1.5.1 South America Parathyroid Hormone Analog Market Status and Trend 2013-2023 1.5.2 Regional Parathyroid Hormone Analog Market Status and Trend 2013-2023 Chapter 2 South America Market Status and Forecast by Regions 2.1 Market Status of Parathyroid Hormone Analog in South America 2013-2017 2.2 Consumption Market of Parathyroid Hormone Analog in South America by Regions 2.2.1 Consumption Volume of Parathyroid Hormone Analog in South America by Regions 2.2.2 Revenue of Parathyroid Hormone Analog in South America by Regions 2.3 Market Analysis of Parathyroid Hormone Analog in South America by Regions 2.3.1 Market Analysis of Parathyroid Hormone Analog in Brazil 2013-2017 2.3.2 Market Analysis of Parathyroid Hormone Analog in Argentina 2013-2017 2.3.3 Market Analysis of Parathyroid Hormone Analog in Venezuela 2013-2017 2.3.4 Market Analysis of Parathyroid Hormone Analog in Colombia 2013-2017 2.3.5 Market Analysis of Parathyroid Hormone Analog in Others 2013-2017 2.4 Market Development Forecast of Parathyroid Hormone Analog in South America 2018-2023 2.4.1 Market Development Forecast of Parathyroid Hormone Analog in South America 2018-2023 2.4.2 Market Development Forecast of Parathyroid Hormone Analog by Regions 2018-2023 Chapter 3 South America Market Status and Forecast by Types 3.1 Whole South America Market Status by Types 3.1.1 Consumption Volume of Parathyroid Hormone Analog in South America by Types 3.1.2 Revenue of Parathyroid Hormone Analog in South America by Types 3.2 South America Market Status by Types in Major Countries 3.2.1 Market Status by Types in Brazil 3.2.2 Market Status by Types in Argentina 3.2.3 Market Status by Types in Venezuela 3.2.4 Market Status by Types in Colombia 3.2.5 Market Status by Types in Others 3.3 Market Forecast of Parathyroid Hormone Analog in South America by Types Chapter 4 South America Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Parathyroid Hormone Analog in South America by Downstream Industry 4.2 Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Major Countries 4.2.1 Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Brazil 4.2.2 Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Argentina 4.2.3 Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Venezuela 4.2.4 Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Colombia 4.2.5 Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Others 4.3 Market Forecast of Parathyroid Hormone Analog in South America by Downstream Industry Chapter 5 Market Driving Factor Analysis of Parathyroid Hormone Analog 5.1 South America Economy Situation and Trend Overview 5.2 Parathyroid Hormone Analog Downstream Industry Situation and Trend Overview Chapter 6 Parathyroid Hormone Analog Market Competition Status by Major Players in South America 6.1 Sales Volume of Parathyroid Hormone Analog in South America by Major Players 6.2 Revenue of Parathyroid Hormone Analog in South America by Major Players 6.3 Basic Information of Parathyroid Hormone Analog by Major Players 6.3.1 Headquarters Location and Established Time of Parathyroid Hormone Analog Major Players 6.3.2 Employees and Revenue Level of Parathyroid Hormone Analog Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Parathyroid Hormone Analog Major Manufacturers Introduction and Market Data 7.1 Natpara (USA) 7.1.1 Company profile 7.1.2 Representative Parathyroid Hormone Analog Product 7.1.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Natpara (USA) 7.2 Pfizer Inc. (USA) 7.2.1 Company profile 7.2.2 Representative Parathyroid Hormone Analog Product 7.2.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Pfizer Inc. (USA) 7.3 Abbott Laboratories (USA) 7.3.1 Company profile 7.3.2 Representative Parathyroid Hormone Analog Product 7.3.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Abbott Laboratories (USA) 7.4 Merck & Co., Inc. (US) 7.4.1 Company profile 7.4.2 Representative Parathyroid Hormone Analog Product 7.4.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. (US) 7.5 GlaxoSmithKline Plc (UK) 7.5.1 Company profile 7.5.2 Representative Parathyroid Hormone Analog Product 7.5.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of GlaxoSmithKline Plc (UK) 7.6 Sanofi SA (France) 7.6.1 Company profile 7.6.2 Representative Parathyroid Hormone Analog Product 7.6.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Sanofi SA (France) 7.7 Eli Lilly and Company (US) 7.7.1 Company profile 7.7.2 Representative Parathyroid Hormone Analog Product 7.7.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Eli Lilly and Company (US) 7.8 Cell Genesys Inc. (USA) 7.8.1 Company profile 7.8.2 Representative Parathyroid Hormone Analog Product 7.8.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Cell Genesys Inc. (USA) 7.9 OSI Pharmaceuticals, Inc. (USA) 7.9.1 Company profile 7.9.2 Representative Parathyroid Hormone Analog Product 7.9.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of OSI Pharmaceuticals, Inc. (USA) 7.10 Paladin Labs Inc. (Canada) 7.10.1 Company profile 7.10.2 Representative Parathyroid Hormone Analog Product 7.10.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Paladin Labs Inc. (Canada) 7.11 ALZA Corporation (USA) 7.11.1 Company profile 7.11.2 Representative Parathyroid Hormone Analog Product 7.11.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of ALZA Corporation (USA) 7.12 Tymlos (USA) 7.12.1 Company profile 7.12.2 Representative Parathyroid Hormone Analog Product 7.12.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Tymlos (USA) 7.13 Forteo (USA） 7.13.1 Company profile 7.13.2 Representative Parathyroid Hormone Analog Product 7.13.3 Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Forteo (USA） Chapter 8 Upstream and Downstream Market Analysis of Parathyroid Hormone Analog 8.1 Industry Chain of Parathyroid Hormone Analog 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Parathyroid Hormone Analog 9.1 Cost Structure Analysis of Parathyroid Hormone Analog 9.2 Raw Materials Cost Analysis of Parathyroid Hormone Analog 9.3 Labor Cost Analysis of Parathyroid Hormone Analog 9.4 Manufacturing Expenses Analysis of Parathyroid Hormone Analog Chapter 10 Marketing Status Analysis of Parathyroid Hormone Analog 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Abaloparatide Table Advantage and Disadvantage of Teriparatide Table Advantage and Disadvantage of Human parathyroid hormone Recombinant Table Consumption Volume of Parathyroid Hormone Analog in South America by Regions 2013-2017 Table Revenue of Parathyroid Hormone Analog in South America by Regions 2013-2017 Table Consumption Volume of Parathyroid Hormone Analog in South America by Regions 2018-2023 Table Revenue of Parathyroid Hormone Analog in South America by Regions 2018-2023 Table Consumption Volume of Parathyroid Hormone Analog in South America by Types 2013-2017 Table Revenue of Parathyroid Hormone Analog in South America by Types 2013-2017 Table Consumption Volume of Parathyroid Hormone Analog by Types in Brazil 2013-2017 Table Consumption Volume of Parathyroid Hormone Analog by Types in Argentina 2013-2017 Table Consumption Volume of Parathyroid Hormone Analog by Types in Venezuela 2013-2017 Table Consumption Volume of Parathyroid Hormone Analog by Types in Colombia 2013-2017 Table Consumption Volume of Parathyroid Hormone Analog by Types in Others 2013-2017 Table Consumption Volume Forecast of Parathyroid Hormone Analog in South America by Types 2018-2023 Table Revenue Forecast of Parathyroid Hormone Analog in South America by Types 2018-2023 Table Demand Volume of Parathyroid Hormone Analog in South America by Downstream Industry 2013-2017 Table Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Brazil 2013-2017 Table Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Argentina 2013-2017 Table Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Venezuela 2013-2017 Table Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Colombia 2013-2017 Table Demand Volume of Parathyroid Hormone Analog by Downstream Industry in Others 2013-2017 Table Demand Volume Forecast of Parathyroid Hormone Analog in South America by Downstream Industry 2018-2023 Table Sales Volume of Parathyroid Hormone Analog in South America by Major Players 2013-2017 Table Revenue of Parathyroid Hormone Analog in South America by Major Players 2013-2017 Table Headquarters Location and Established Time of Parathyroid Hormone Analog Major Players Table Employees and Revenue Level of Parathyroid Hormone Analog Major Players Table Representative Parathyroid Hormone Analog Product One of Natpara (USA) Table Representative Parathyroid Hormone Analog Product Two of Natpara (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Natpara (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Pfizer Inc. (USA) Table Representative Parathyroid Hormone Analog Product Two of Pfizer Inc. (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Pfizer Inc. (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Abbott Laboratories (USA) Table Representative Parathyroid Hormone Analog Product Two of Abbott Laboratories (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Abbott Laboratories (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Merck & Co., Inc. (US) Table Representative Parathyroid Hormone Analog Product Two of Merck & Co., Inc. (US) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. (US) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of GlaxoSmithKline Plc (UK) Table Representative Parathyroid Hormone Analog Product Two of GlaxoSmithKline Plc (UK) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of GlaxoSmithKline Plc (UK) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Sanofi SA (France) Table Representative Parathyroid Hormone Analog Product Two of Sanofi SA (France) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Sanofi SA (France) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Eli Lilly and Company (US) Table Representative Parathyroid Hormone Analog Product Two of Eli Lilly and Company (US) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Eli Lilly and Company (US) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Cell Genesys Inc. (USA) Table Representative Parathyroid Hormone Analog Product Two of Cell Genesys Inc. (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Cell Genesys Inc. (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of OSI Pharmaceuticals, Inc. (USA) Table Representative Parathyroid Hormone Analog Product Two of OSI Pharmaceuticals, Inc. (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of OSI Pharmaceuticals, Inc. (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Paladin Labs Inc. (Canada) Table Representative Parathyroid Hormone Analog Product Two of Paladin Labs Inc. (Canada) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Paladin Labs Inc. (Canada) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of ALZA Corporation (USA) Table Representative Parathyroid Hormone Analog Product Two of ALZA Corporation (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of ALZA Corporation (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Tymlos (USA) Table Representative Parathyroid Hormone Analog Product Two of Tymlos (USA) Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Tymlos (USA) 2013-2017 Table Representative Parathyroid Hormone Analog Product One of Forteo (USA） Table Representative Parathyroid Hormone Analog Product Two of Forteo (USA） Table Parathyroid Hormone Analog Sales, Revenue, Price and Gross Margin of Forteo (USA） 2013-2017